Is stenting a treatment option for oesophageal varices?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stenting for Esophageal Varices: Treatment Options and Recommendations

Self-expandable metal stents (SEMS) can be used as a rescue therapy for refractory esophageal variceal bleeding, but they are not recommended as a primary treatment option for esophageal varices. The primary treatments remain endoscopic variceal ligation (EVL) and transjugular intrahepatic portosystemic shunt (TIPS).

Primary Management of Esophageal Varices

First-Line Therapy

  • Endoscopic Variceal Ligation (EVL): Recommended as the primary endoscopic treatment for acute esophageal variceal bleeding 1
  • Pharmacological Therapy: Vasoactive agents (terlipressin, somatostatin, or octreotide) should be initiated as soon as possible after admission 1
  • Combined Approach: Combination of endoscopic and pharmacological therapy is superior to either treatment alone, with 5-day hemostasis rates of 77% vs. 58% for endoscopy alone 1

For Refractory Bleeding

When first-line therapy fails to control bleeding, the following options should be considered:

  1. TIPS (Transjugular Intrahepatic Portosystemic Shunt):

    • Recommended as the best rescue treatment for patients with inadequate bleeding control despite combined pharmacological and endoscopic therapy 1
    • Achieves control of bleeding in approximately 90% of patients 1
    • Early TIPS (within 72 hours, ideally <24 hours) should be considered in high-risk patients (Child-Pugh class B with active bleeding or Child-Pugh class C with MELD <14) 1
    • Covered stents are now standard practice due to significantly improved patency rates 1
  2. Self-Expandable Metal Stents (SEMS):

    • Can be used as a bridge therapy when standard treatments fail 2, 3
    • Initial bleeding control rate after SEMS application is approximately 100% 2
    • Provides a safer alternative to balloon tamponade with better control of bleeding (85% vs. 47%) and fewer serious adverse events (15% vs. 47%) 4
    • Can remain in place for up to 2 weeks 1
    • May be considered for definitive treatment in patients with limited life expectancy or those unsuitable for TIPS 5
  3. Balloon Tamponade:

    • Traditional bridge therapy that provides hemostasis in 80-90% of patients 1
    • High rebleeding rate (approximately 50%) after deflation 1
    • Associated with serious complications (esophageal ulceration, rupture, aspiration pneumonia) 1
    • Should not exceed 24 hours of use 1

Limitations and Complications

TIPS Complications

  • Hepatic encephalopathy (15-25% of patients) 1
  • Risk of hepatic decompensation due to diversion of portal flow 1
  • Not recommended where the Child-Pugh score is >13 1

SEMS Complications

  • Stent migration/dislocation (reported in up to 63.6% of cases) 2
  • May require multiple procedures for placement and removal

Decision Algorithm

  1. Initial Management:

    • Start vasoactive drugs immediately upon suspicion of variceal bleeding
    • Perform endoscopic therapy (preferably EVL) once patient is stable
    • Add antibiotic prophylaxis
  2. If Bleeding Persists or Recurs Within 5 Days:

    • For hemodynamically stable patients with Child's C disease (C10-13) or MELD ≥19: Consider early TIPS within 72 hours
    • For other patients with refractory bleeding: Consider rescue TIPS
  3. If TIPS is Contraindicated or Not Immediately Available:

    • Consider SEMS as a bridge therapy (can remain in place for up to 2 weeks)
    • SEMS is preferable to balloon tamponade due to better efficacy and safety profile
  4. For Long-Term Management:

    • TIPS with covered stents for patients who have failed endoscopic and pharmacological therapy
    • SEMS may be considered as definitive treatment only in patients with limited life expectancy or those unsuitable for TIPS

Important Considerations

  • Stent migration is common with SEMS (63.6%) but doesn't necessarily lead to rebleeding 2
  • TIPS should be performed with covered stents due to superior patency rates 1
  • The goal portal pressure gradient after TIPS should be <12 mmHg 6
  • Concurrent obliteration of varices is recommended during TIPS creation 6

In conclusion, while stenting with SEMS can be an effective rescue therapy for refractory esophageal variceal bleeding, it is primarily used as a bridge to more definitive treatment (usually TIPS) rather than as a primary treatment option for esophageal varices.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.